The Discounted Cash Flow (DCF) valuation of China Regenerative Medicine International Ltd (8158.HK) is 0.40 HKD. With the latest stock price at 0.58 HKD, the upside of China Regenerative Medicine International Ltd based on DCF is -30.8%.
Based on the latest price of 0.58 HKD and our DCF valuation, China Regenerative Medicine International Ltd (8158.HK) is a sell. selling 8158.HK stocks now will result in a potential gain of 30.8%.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 7.4% | 6.5% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 0.23 - 0.93 | 0.40 |
| Upside | -59.6% - 60.2% | -30.8% |